These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 238091)

  • 1. A systems and control theory approach to dynamic neurotransmitter balance in narcotic addiction and narcotic antagonism.
    Kaufman JJ; Koski WS; Peat K
    Life Sci; 1975 Jul; 17(1):83-4. PubMed ID: 238091
    [No Abstract]   [Full Text] [Related]  

  • 2. Central neurohumoral systems involved with narcotic agonists and antagonists.
    Harris LS
    Fed Proc; 1970; 29(1):28-31. PubMed ID: 4391649
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible actions of opiates upon synapses.
    Eidelberg E
    Prog Neurobiol; 1976; 3(2):81-102. PubMed ID: 6994
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of narcotic agents on temperature regulation.
    Ary M; Lomax P
    Adv Biochem Psychopharmacol; 1979; 20():429-51. PubMed ID: 38642
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible role of cyclic AMP and dopamine in morphine tolerance and physical dependence.
    Mehta CS; Johnson WE
    Life Sci; 1975 Jun; 16(12):1883-8. PubMed ID: 168450
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphine-induced increases in the incorporation of 14 C-Tyrosine into 14 C-Dopamine and 14 C-norepinephrine in the mouse brain: antagonism by naloxone and tolerance.
    Smith CB; Sheldon MI; Bednarczyk JH; Villarreal JE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):547-57. PubMed ID: 5012782
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex.
    Chen JC; Li JY; Liang KW; Huang YK
    Brain Res; 1999 Jan; 816(1):220-4. PubMed ID: 9878747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of neurotransmitters in the neocortex.
    Coyle JT
    Neurosci Res Program Bull; 1982 Apr; 20(4):479-91. PubMed ID: 6126844
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemistry of mood and emotion.
    McGeer PL; McGeer EG
    Annu Rev Psychol; 1980; 31():273-307. PubMed ID: 6102450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tranquilizers and neurotransmitters].
    Ueki S; Yamamoto T
    Nihon Rinsho; 1978; 36(1):95-102. PubMed ID: 24769
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotransmitter receptors in the brain: biochemical identification.
    Snyder SH; Bennett JP
    Annu Rev Physiol; 1976; 38():153-75. PubMed ID: 4007
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous opioids stimulate norepinephrine and acetylcholine release in spinal cord dorsal horn. Systematic studies in sheep and an observation in a human.
    Bouaziz H; Tong C; Yoon Y; Hood DD; Eisenach JC
    Anesthesiology; 1996 Jan; 84(1):143-54. PubMed ID: 8572328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence.
    Bhargava HN; Way EL
    J Pharmacol Exp Ther; 1974 Jul; 190(1):165-75. PubMed ID: 4858783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary research on multi-neurotransmitters' change regulation in 120 depression patients' brains].
    Chi M; Qing XM; Pan YS; Xu FQ; Liu C; Zhang C; Xu ZH
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1516-24. PubMed ID: 25039193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis at synaptic level of the morphine action in striatum and N. accumbens: dopamine and acetylcholine interactions.
    Costa E; Cheney DL; Racagni G; Zsilla G
    Life Sci; 1975 Jul; 17(1):1-8. PubMed ID: 167253
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological challenge strategies: implications for neurochemical mechanisms in affective disorders and treatment approaches.
    Risch SC; Kalin NH; Murphy DL
    J Clin Psychopharmacol; 1981 Jul; 1(4):238-43. PubMed ID: 6117587
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurohumoral interactions and basal ganglia function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alzheimer's disease and neurotransmitters].
    Nakamura S
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):30-40. PubMed ID: 1672465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interaction of opiates and opioid peptides with cerebral mediator systems].
    Bulaev VM; Raevskiĭ KS
    Usp Fiziol Nauk; 1982; 13(2):65-92. PubMed ID: 6124068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.